Patents by Inventor Stefan Hosch

Stefan Hosch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12228258
    Abstract: A linear luminaire includes a linear channel defining an interior space and a linear light inset configured for being inserted into the channel in the interior space. The light inset includes a cover and a printed circuit board fixed to the cover. The printed circuit board supports a plurality of light emitting diodes. The cover base wall includes a translucent portion. The light emitting diodes are arranged for emitting light through the translucent portion. The cover includes two cover connectors, each configured for being snapped into the channel to hold the cover in the interior space. The cover connectors are on an opposite side of the printed circuit board as the translucent portion.
    Type: Grant
    Filed: November 15, 2023
    Date of Patent: February 18, 2025
    Assignee: DIEM GmbH
    Inventors: Stefan Krotmeier, Dominic Hosch, Moritz Gessner, Rene Hendler
  • Patent number: 7132288
    Abstract: Disclosed is a medium for cultivating tumor cells, comprising the following constituents, as comprised for example in the medium RPMI 1640: (a) fetal calf serum (FCS), (b) penicillin-streptomycin, (c) L-glutamine, (d) transferrin, (e) insulin, (f) human epidermal growth factor (EGF) and (g) ?-TGF. A method for characterizing tumor cells or potential tumor cells, respectively, is also described. Said method includes the culturing of cells in the inventive medium and the two tumor cell lines LNHOS1 and PTHOS1 established by means of the inventive culturing method.
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: November 7, 2006
    Assignee: Uni-Klinikum Hamburg-Eppendorf
    Inventors: Jakob Izbicki, Stefan Hosch, Peter Scheunemann
  • Publication number: 20040067581
    Abstract: Disclosed is a medium for cultivating tumor cells, comprising the following constituents, as comprised for example in the medium RPMI 1640: (a) fetal calf serum (FCS), (b) penicillin-streptomycin, (c) L-glutamine, (d) transferrin, (e) insulin, (f) human epidermal growth factor (EGF) and (g) &agr;-TGF. A method for characterizing tumor cells or potential tumor cells, respectively, is also described. Said method includes the culturing of cells in the inventive medium and the two tumor cell lines LNHOS1 and PTHOS1 established by means of the inventive culturing method.
    Type: Application
    Filed: August 13, 2003
    Publication date: April 8, 2004
    Inventors: Jakob Izbicki, Stefan Hosch, Peter Scheunemann